{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T19:34:01Z","timestamp":1777923241724,"version":"3.51.4"},"reference-count":20,"publisher":"SAGE Publications","issue":"9","license":[{"start":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T00:00:00Z","timestamp":1693180800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Microbial Drug Resistance"],"published-print":{"date-parts":[[2023,9]]},"abstract":"\n Aim:<\/jats:title>\n \n This study aimed to establish the\n in vitro<\/jats:italic>\n efficacy and susceptibility profiles of new \u03b2-lactam antibiotics against clinically isolated carbapenemase-producing\n Klebsiella pneumoniae<\/jats:italic>\n (CPKP) strains.\n <\/jats:p>\n <\/jats:sec>\n \n Materials and Methods:<\/jats:title>\n A total of 117 nonduplicated CPKP isolates were tested against cefiderocol, cefepime-zidebactam, ceftazidime-avibactam, tigecycline, and other 20 antibiotics by broth microdilution. The carbapenemase genes were identified using PCR and sequencing, while multilocus sequence typing established the bacterial strains.<\/jats:p>\n <\/jats:sec>\n \n Results:<\/jats:title>\n \n Three significant sequence types (STs), including ST147, ST16, and ST11, were shown to be the dominant STs, which occupied \u223c90% of the tested population. Three carbapenemase genes,\n bla<\/jats:italic>\n NDM-1<\/jats:sub>\n ,\n bla<\/jats:italic>\n OXA-181,<\/jats:sub>\n and\n bla<\/jats:italic>\n OXA-232<\/jats:sub>\n , were detected. The\n bla<\/jats:italic>\n NDM-1<\/jats:sub>\n was found in ST147 and ST16 but not in ST11, while the\n bla<\/jats:italic>\n OXA-232<\/jats:sub>\n was not detected in ST147. The majority of ST16 isolates contained both\n bla<\/jats:italic>\n NDM-1<\/jats:sub>\n and\n bla<\/jats:italic>\n OXA-232<\/jats:sub>\n , which was not seen in other strains. Cefiderocol, cefepime-zidebactam, and tigecycline were the most active agents against CPKP. Both MIC\n 50<\/jats:sub>\n and MIC\n 90<\/jats:sub>\n of these three antibiotics remained within the susceptible categories, while nearly all other antibiotics were in the resistant levels. However, in ST11, which carried only\n bla<\/jats:italic>\n OXA<\/jats:sub>\n genes without\n bla<\/jats:italic>\n NDM-1<\/jats:sub>\n , ceftazidime-avibactam was effective with the MIC\n 90<\/jats:sub>\n at 2\u2009\u03bcg\/mL. In addition, amikacin was shown to have good activity in ST11. In contrast, gentamicin was active in only ST16 and ST147.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions:<\/jats:title>\n This study is the first report that demonstrates the prevalence of CPKP, distribution of strains, resistant genes, and antimicrobial susceptibility profiles in northern Thailand. These data would contribute to appropriate individual treatment and the selection of infection control strategies.<\/jats:p>\n <\/jats:sec>","DOI":"10.1089\/mdr.2023.0070","type":"journal-article","created":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T11:24:11Z","timestamp":1688556251000},"page":"416-422","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["In Vitro<\/i>\n Activity of Cefiderocol, Cefepime-Zidebactam, and \u03b2-Lactam Combinations Versus Other Antibiotic Classes Against Various Sequence Types of Clinically Isolated Carbapenemase-Producing\n Klebsiella pneumoniae<\/i>"],"prefix":"10.1177","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1126-1818","authenticated-orcid":false,"given":"Phadungkiat","family":"Khamnoi","sequence":"first","affiliation":[{"name":"Microbiology Unit, Diagnostic Laboratory, Maharaj Nakorn Chiang Mai Hospital, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand."},{"name":"Department of Medical Technology, Faculty of Allied Health Science, Naresuan University, Phitsanulok, Thailand."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noppadon","family":"Jumroon","sequence":"additional","affiliation":[{"name":"Department of Medical Technology, Faculty of Allied Health Science, Naresuan University, Phitsanulok, Thailand."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jakkrit","family":"Khamphakul","sequence":"additional","affiliation":[{"name":"Microbiology Laboratory, Department of Pathology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narong","family":"Chaihongsa","sequence":"additional","affiliation":[{"name":"Microbiology Laboratory, Department of Pathology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3914-1367","authenticated-orcid":false,"given":"Pitak","family":"Santanirand","sequence":"additional","affiliation":[{"name":"Microbiology Laboratory, Department of Pathology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2023,8,28]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)02724-0"},{"key":"e_1_3_4_3_2","doi-asserted-by":"crossref","first-page":"823684","DOI":"10.3389\/fcimb.2022.823684","article-title":"Global threat of carbapenem-resistant gram-negative bacteria","volume":"12","author":"Jean SS","year":"2022","unstructured":"Jean SS, , Harnod D, , Hsueh PR. Global threat of carbapenem-resistant gram-negative bacteria. Front Cell Infect Microbiol, 2022; 12:823684; doi: 10.3389\/fcimb.2022.823684","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"e_1_3_4_4_2","first-page":"e00102","article-title":"The global ascendency of OXA-48-type carbapenemases","volume":"33","author":"Pitout JDD","year":"2019","unstructured":"Pitout JDD, , Peirano G, , Kock MM, et al. The global ascendency of OXA-48-type carbapenemases. Clin Microbiol Rev, 2019; 33(1):e00102-19; doi: 10.1128\/CMR.00102-19","journal-title":"Clin Microbiol Rev"},{"issue":"7","key":"e_1_3_4_5_2","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.jiac.2020.02.002","article-title":"Trends and molecular characteristics of carbapenemase-producing Enterobacteriaceae in Japanese hospital from 2006 to 2015","volume":"26","author":"Eda R","year":"2020","unstructured":"Eda R, , Nakamura M, , Takayama Y, et al. Trends and molecular characteristics of carbapenemase-producing Enterobacteriaceae in Japanese hospital from 2006 to 2015. J Infect Chemother, 2020; 26(7):667\u2013671; doi: 10.1016\/j.jiac.2020.02.002","journal-title":"J Infect Chemother"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/305784"},{"issue":"1","key":"e_1_3_4_7_2","doi-asserted-by":"crossref","first-page":"e00115","DOI":"10.1128\/CMR.00115-20","article-title":"New \u03b2-lactam-\u03b2-lactamase inhibitor combinations","volume":"34","author":"Yahav D","year":"2020","unstructured":"Yahav D, , Giske CG, , Gr\u0101matniece A, et al. New \u03b2-lactam-\u03b2-lactamase inhibitor combinations. Clin Microbiol Rev, 2020; 34(1):e00115-20; doi: 10.1128\/CMR.00115-20","journal-title":"Clin Microbiol Rev"},{"issue":"2","key":"e_1_3_4_8_2","doi-asserted-by":"crossref","first-page":"e0167621","DOI":"10.1128\/AAC.01676-21","article-title":"Assessment of activity and resistance mechanisms to cefepime in combination with the novel \u03b2-lactamase inhibitors zidebactam, taniborbactam, and enmetazobactam against a multicenter collection of carbapenemase-producing Enterobacterales","volume":"66","author":"V\u00e1zquez-Ucha JC","year":"2022","unstructured":"V\u00e1zquez-Ucha JC, , Lasarte-Monterrubio C, , Guijarro-S\u00e1nchez P, et al. Assessment of activity and resistance mechanisms to cefepime in combination with the novel \u03b2-lactamase inhibitors zidebactam, taniborbactam, and enmetazobactam against a multicenter collection of carbapenemase-producing Enterobacterales. Antimicrob Agents Chemother, 2022; 66(2):e0167621; doi: 10.1128\/AAC.01676-21","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"e_1_3_4_9_2","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1080\/14787210.2022.2021876","article-title":"Multicenter surveillance of in vitro activities of cefepime-zidebactam, cefepime-enmetazobactam, omadacycline, eravacycline, and comparator antibiotics against Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter baumannii complex causing bloodstream infection in Taiwan 2020","volume":"20","author":"Jean SS","year":"2022","unstructured":"Jean SS, , Ko WC, , Lu MC, et al. Multicenter surveillance of in vitro activities of cefepime-zidebactam, cefepime-enmetazobactam, omadacycline, eravacycline, and comparator antibiotics against Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter baumannii complex causing bloodstream infection in Taiwan 2020. Expert Rev Anti Infect Ther, 2022; 20(6):941\u2013953; doi: 10.1080\/14787210.2022.2021876","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"3","key":"e_1_3_4_10_2","doi-asserted-by":"crossref","first-page":"106377","DOI":"10.1016\/j.ijantimicag.2021.106377","article-title":"In-vitro activity of cefiderocol, cefepime\/zidebactam, cefepime\/enmetazobactam, omadacycline, eravacycline and other comparative agents against carbapenem-nonsusceptible Enterobacterales: Results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2017\u20132020","volume":"58","author":"Lee YL","year":"2021","unstructured":"Lee YL, , Ko WC, , Lee WS, et al. In-vitro activity of cefiderocol, cefepime\/zidebactam, cefepime\/enmetazobactam, omadacycline, eravacycline and other comparative agents against carbapenem-nonsusceptible Enterobacterales: Results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2017\u20132020. Int J Antimicrob Agents, 2021; 58(3):106377; doi: 10.1016\/j.ijantimicag.2021.106377","journal-title":"Int J Antimicrob Agents"},{"issue":"8","key":"e_1_3_4_11_2","doi-asserted-by":"crossref","first-page":"e0217120","DOI":"10.1128\/AAC.02171-20","article-title":"New perspectives on antimicrobial agents: Cefiderocol","volume":"65","author":"McCreary EK","year":"2021","unstructured":"McCreary EK, , Heil EL, , Tamma PD. New perspectives on antimicrobial agents: Cefiderocol. Antimicrob Agents Chemother, 2021; 65(8):e0217120; doi: 10.1128\/AAC.02171-20","journal-title":"Antimicrob Agents Chemother"},{"key":"e_1_3_4_12_2","unstructured":"Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; M100 32nd edition. Clinical and Laboratory Standards Institute: Wayne PA; 2022."},{"issue":"5","key":"e_1_3_4_13_2","doi-asserted-by":"crossref","first-page":"e0005422","DOI":"10.1128\/aac.00054-22","article-title":"Leaks in the pipeline: A failure analysis of gram-negative antibiotic development from 2010 to 2020","volume":"66","author":"Prasad NK","year":"2022","unstructured":"Prasad NK, , Seiple IB, , Cirz RT, et al. Leaks in the pipeline: A failure analysis of gram-negative antibiotic development from 2010 to 2020. Antimicrob Agents Chemother, 2022; 66(5):e0005422; doi: 10.1128\/aac.00054-22","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"e_1_3_4_14_2","first-page":"000797","article-title":"Nationwide surveillance in Thailand revealed genotype-dependent dissemination of carbapenem-resistant Enterobacterales","volume":"8","author":"Takeuchi D","year":"2022","unstructured":"Takeuchi D, , Kerdsin A, , Akeda Y, et al. Nationwide surveillance in Thailand revealed genotype-dependent dissemination of carbapenem-resistant Enterobacterales. Microb Genom, 2022; 8(4):000797; doi: 10.1099\/mgen.0.000797","journal-title":"Microb Genom"},{"key":"e_1_3_4_15_2","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jgar.2020.09.004","article-title":"Virulence evolution, molecular mechanisms of resistance and prevalence of ST11 carbapenem-resistant Klebsiella pneumoniae in China: A review over the last 10 years","volume":"23","author":"Liao W","year":"2020","unstructured":"Liao W, , Liu Y, , Zhang W. Virulence evolution, molecular mechanisms of resistance and prevalence of ST11 carbapenem-resistant Klebsiella pneumoniae in China: A review over the last 10 years. J Glob Antimicrob Resist, 2020; 23:175\u2013180; doi: 10.1016\/j.jgar.2020.09.004","journal-title":"J Glob Antimicrob Resist"},{"issue":"10","key":"e_1_3_4_16_2","doi-asserted-by":"crossref","first-page":"e0274419","DOI":"10.1371\/journal.pone.0274419","article-title":"Fecal carriage and clonal dissemination of blaNDM-1 carrying Klebsiella pneumoniae sequence type 147 at an intensive care unit in Lao PDR","volume":"17","author":"Sewunet T","year":"2022","unstructured":"Sewunet T, , Sriram KK, , Nguyen HH, et al. Fecal carriage and clonal dissemination of blaNDM-1 carrying Klebsiella pneumoniae sequence type 147 at an intensive care unit in Lao PDR. PLoS One, 2022; 17(10):e0274419; doi: 10.1371\/journal.pone.0274419","journal-title":"PLoS One"},{"issue":"11","key":"e_1_3_4_17_2","doi-asserted-by":"crossref","first-page":"e857","DOI":"10.1016\/S2666-5247(22)00181-1","article-title":"Genomic characterization of multidrug-resistant Escherichia coli, Klebsiella pneumoniae, and Acinetobacter baumannii in two intensive care units in Hanoi, Viet Nam: A prospective observational cohort study","volume":"3","author":"Roberts LW","year":"2022","unstructured":"Roberts LW, , Hoi LT, , Khokhar FA, et al. Genomic characterization of multidrug-resistant Escherichia coli, Klebsiella pneumoniae, and Acinetobacter baumannii in two intensive care units in Hanoi, Viet Nam: A prospective observational cohort study. Lancet Microbe, 2022; 3(11):e857\u2013e866; doi: 10.1016\/S2666-5247(22)00181-1","journal-title":"Lancet Microbe"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1089\/mdr.2018.0080"},{"issue":"7","key":"e_1_3_4_19_2","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1093\/jac\/dkaa117","article-title":"Activity of cefiderocol against high-risk clones of multidrug-resistant Enterobacterales, Acinetobacter baumannii, Pseudomonas aeruginosa and Stenotrophomonas maltophilia","volume":"75","author":"Delgado-Valverde M","year":"2020","unstructured":"Delgado-Valverde M, , Conejo MDC, , Serrano L, et al. Activity of cefiderocol against high-risk clones of multidrug-resistant Enterobacterales, Acinetobacter baumannii, Pseudomonas aeruginosa and Stenotrophomonas maltophilia. J Antimicrob Chemother, 2020; 75(7):1840\u20131849; doi: 10.1093\/jac\/dkaa117","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"e_1_3_4_20_2","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1093\/cid\/ciac078","article-title":"Cefiderocol for the treatment of infections due to metallo-\u03b2-lactamase-producing pathogens in the CREDIBLE-CR and APEKS-NP phase 3 randomized studies","volume":"75","author":"Timsit JF","year":"2022","unstructured":"Timsit JF, , Paul M, , Shields RK, et al. Cefiderocol for the treatment of infections due to metallo-\u03b2-lactamase-producing pathogens in the CREDIBLE-CR and APEKS-NP phase 3 randomized studies. Clin Infect Dis, 2022; 75(6):1081\u20131084; doi: 10.1093\/cid\/ciac078","journal-title":"Clin Infect Dis"},{"issue":"1","key":"e_1_3_4_21_2","doi-asserted-by":"crossref","first-page":"115745","DOI":"10.1016\/j.diagmicrobio.2022.115745","article-title":"Comparison of ceftazidime-avibactam susceptibility testing methods against OXA-48-like carrying Klebsiella blood stream isolates","volume":"104","author":"Isler B","year":"2022","unstructured":"Isler B, , Vatansever C, , \u00d6zer B, et al. Comparison of ceftazidime-avibactam susceptibility testing methods against OXA-48-like carrying Klebsiella blood stream isolates. Diagn Microbiol Infect Dis, 2022; 104(1):115745; doi: 10.1016\/j.diagmicrobio.2022.115745","journal-title":"Diagn Microbiol Infect Dis"}],"container-title":["Microbial Drug Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/mdr.2023.0070","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/mdr.2023.0070","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/mdr.2023.0070","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T20:41:04Z","timestamp":1777668064000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.1089\/mdr.2023.0070"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,28]]},"references-count":20,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["10.1089\/mdr.2023.0070"],"URL":"https:\/\/doi.org\/10.1089\/mdr.2023.0070","relation":{},"ISSN":["1076-6294","1931-8448"],"issn-type":[{"value":"1076-6294","type":"print"},{"value":"1931-8448","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,28]]}}}